Bioequivalence study of telmisartan tablets in healthy volunteers
Wang Jing-tian
Abstract
Wang Jing-tian
Abstract
Objective To study the bioequivalence of telmisartan tablets in healthy volunteers.Methods Telmisartan concentrations in serum were determined by LC-MS after a single oral dose of 80mg of telmisartan tablet or reference telmisartan tablet was given to 20 healthy male volunteers in an randomized cross-over design.The pharmacokinetic parameters and relative bioavailability were calculated by SPSS program to evaluate the bioequivalence of two preparations. Results AUC_(0→96) of reference and test drug were 2910.5± 289.6 and 2866.8± 235.5 μ g·h·L~(-1), C_(max) were 347.2± 41.1 and 352.4± 42.9 μ g·L~(-1), t_(max) were 1.1± 0.25 and 1.1± 0.21 h, respectively. Conclusion The 2 preparations are bioequivalent.The relative bioavailability of the test drug was (98.9± 7.0)%. The two preparations are bioequivallent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the bioequivalence of telmisartan tablets in healthy volunteers.Methods Telmisartan concentrations in serum were determined by LC-MS after a single oral dose of 80mg of telmisartan tablet or reference telmisartan tablet was given to 20 healthy male volunteers in an randomized cross-over design.The pharmacokinetic parameters and relative bioavailability were calculated by SPSS program to evaluate the bioequivalence of two preparations. Results AUC_(0→96) of reference and test drug were 2910.5± 289.6 and 2866.8± 235.5 μ g·h·L~(-1), C_(max) were 347.2± 41.1 and 352.4± 42.9 μ g·L~(-1), t_(max) were 1.1± 0.25 and 1.1± 0.21 h, respectively. Conclusion The 2 preparations are bioequivalent.The relative bioavailability of the test drug was (98.9± 7.0)%. The two preparations are bioequivallent.
Key concepts: Bioequivalence, Telmisartan, Bioavailability, Pharmacology, Pharmacokinetics, Medicine, Internal medicine, Blood pressure